Harrow Health, Inc. Soared
Harrow Health, Inc. (HROW:NASDAQ) jumped higher at $33.92, a gain of 54.3%. On Thu, Aug 08, 2024, HROW:NASDAQ touched a New 2-Week High of $33.92. The stock got featured on our News Catalysts scanner on Wed, Aug 07, 2024 at 05:27 PM in the 'EARNINGS' category. From Thu, Jul 25, 2024, the stock recorded 30.00% Up Days and 36.36% Green Days
About Harrow Health, Inc. (HROW:NASDAQ)
Imprimis Pharmaceuticals Inc is an ophthalmology-focused pharmaceutical company. The company is specialized in the development, production, and sale of medications that offer competitive advantages and serve unmet needs in the marketplace. Its cornerstone of ophthalmology program consists of proprietary Dropless Therapy injectable and LessDrops topical formulations that are designed to address patient compliance issues and provide other compelling medical and economic benefits.
Top 10 Gainers:
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 122.22%
- Kubient Inc. (KBNT:NASDAQ), 100%
- SRAX, Inc. (SRAX:NASDAQ), 100%
- NextPlay Technologies Inc. (NXTP:NASDAQ), 76.92%
- Digital Turbine, Inc. (APPS:NASDAQ), 61.8%
- Harrow Health, Inc. (HROW:NASDAQ), 54.32%
- MGO Global Inc. (MGOL:NASDAQ), 52.26%
- XPEL, Inc. (XPEL:NASDAQ), 47.69%
- SkyWater Technology Inc. (SKYT:NASDAQ), 47.55%
- Emergent BioSolutions Inc. (EBS:NYSE), 46.85%